Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index; 1 of the 19 sources its claims cite were checked for support.
Abstract
To determine the plasma epinephrine thresholds for its metabolic and hemodynamic actions and plasma epinephrine metabolic clearance rates, 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 microgram/min were performed in each of six normal human subjects. These 30 infusions resulted in steady-state plasma epinephrine concentrations ranging from 24 to 1,020 pg/ml. Plasma epinephrine thresholds were 50-100 pg/ml for increments in heart rate, 75-125 pg/ml for increments in blood glycerol and systolic blood pressure, 150-200 pg/ml for increments in plasma glucose (the resultant of increments in glucose production and decrements in glucose clearance), blood lactate, blood beta-hydroxybutyrate, and diastolic blood pressure, and greater than 400 pg/ml for early decrements in plasma insulin. Changes in blood alanine, plasma glucagon, plasma growth hormone, and plasma cortisol were not detected. At steady-state plasma epinephrine concentrations of 24-74 pg/ml, values overlapping the basal normal range, the mean (+/-SE) plasma metabolic clearance rate of epinephrine was 52 +/- 4 ml x min-1 x kg-1; this value rose to 89 +/- 6 ml x min-1 x kg-1 (P less than 0.01) at steady-state epinephrine concentrations of 90-1,020 pg/ml. We conclude that in human subjects: (a) the plasma epinephrine thresholds for its hemodynamic and metabolic actions lie within the physiologic range, (b) epinephrine and norepinephrine accelerate their own metabolic clearance, and (c) epinephrine is 10 times more potent than norepinephrine.
Overview
CoChat Summary
TL;DR
In six normal human subjects, graded epinephrine infusions showed that hemodynamic and metabolic thresholds occur within the physiologic plasma epinephrine range. The study also found that epinephrine accelerates its own metabolic clearance and is about 10 times more potent than norepinephrine.
Key findings
- Across 30 infusions, steady-state plasma epinephrine concentrations ranged from 24 to 1,020 pg/ml. Thresholds were 50–100 pg/ml for heart-rate increments; 75–125 pg/ml for systolic blood pressure and blood glycerol increments; 150–200 pg/ml for plasma glucose, glucose production, glucose clearance, blood lactate, blood β-hydroxybutyrate, and diastolic blood pressure changes; and >400 pg/ml for early plasma insulin decrements. No significant changes were detected in blood alanine, plasma glucagon, growth hormone, or cortisol.
- Plasma epinephrine metabolic clearance rate was 52±4 ml·min⁻¹·kg⁻¹ at steady-state epinephrine concentrations of 24–74 pg/ml, overlapping the basal normal range, and rose to 89±6 ml·min⁻¹·kg⁻¹ at 90–1,020 pg/ml (P < 0.01), an approximately 70% increase.
- From earlier norepinephrine data, plasma norepinephrine metabolic clearance rate was 25±4 ml·min⁻¹·kg⁻¹ at 229–345 pg/ml and 39±3 ml·min⁻¹·kg⁻¹ at higher levels (P < 0.02), suggesting catecholamines accelerate their own clearance.
- Epinephrine thresholds for direct metabolic and hemodynamic effects (<200 pg/ml) were about 10% of previously determined norepinephrine thresholds (1,500–2,000 pg/ml), indicating epinephrine is ~10-fold more potent.
Methods
- Six normal subjects (five men, one woman) each received five 60-min intravenous epinephrine infusions at nominal rates of 0.1, 0.5, 1.0, 2.5, and 5.0 μg/min after an overnight fast, supine, with infusions separated by at least 1 wk.
- Plasma epinephrine and norepinephrine were measured by a single isotope derivative method; glucose by glucose oxidase; insulin, glucagon, and growth hormone by radioimmunoassay; cortisol by competitive protein binding; lactate, alanine, β-hydroxybutyrate, and glycerol by microfluorometric enzymatic techniques. Glucose kinetics used a primed continuous infusion of [6,6-²H₂]glucose with Steele’s equations for nonsteady-state conditions.
- Plasma epinephrine metabolic clearance rate was calculated as measured infusion rate divided by the difference between steady-state and basal plasma epinephrine. Thresholds were estimated by inspection of semilogarithmic plots, extending regression lines through changed data points to the line of no change, and tended to be confirmed by nonlinear least squares regression.
Limitations
- The paper states that the metabolic clearance calculation assumes basal endogenous epinephrine release continues during infusion; if endogenous release ceases, the calculation overestimates clearance, especially at lower steady-state concentrations. It also states that extremity epinephrine uptake may cause overestimation of epinephrine clearance and underestimation of norepinephrine clearance.
- The paper states that threshold estimates were obtained by inspection and extrapolation of the central linear portion of sigmoidal dose-response curves, providing a maximum estimate; nonlinear least squares regression tended to confirm these values.
- Evident from the text: the sample was small (six normal subjects, five men and one woman), and the study examined only normal human subjects, so findings may not generalize to women, other populations, or pathophysiologic states. The authors also note one discrepancy with earlier studies: they did not observe an increase in plasma glucagon during epinephrine infusions.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 10 Not checked · 36 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As noted earlier, plasma epinephrine concentrations of this magnitude do occur during heavy exercise and absolute hypoglycemia, as well as during a variety of acute illnesses.”
What the sources say
- Not checked — no full text of the sourcecites [27] Galbo, H., J. J. Holst, and N. J. Christensen. 1975. Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. J. Appl. Physiol. 38: 70–76. source
- Partly supportedcites [28] Garber, A. J., P. E. Cryer, J. V. Santiago, M. W. Haymond, A. S. Pagliara, and D. M. Kipnis. 1976. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Invest. 58: 7-15. sourceExperimental — accuracy not yet measured
Our copy supports only the hypoglycemia limb of the claim: RESULTS p. 4 reports mean plasma epinephrine rising from 43±2 pg/ml to maximal levels of 2,200±660 pg/ml (50× basal) during insulin-induced hypoglycemia (plasma glucose 89±3 → 39±2 mg/dl, INTRODUCTION p. 1), i.e. concentrations far above 400 pg/ml in absolute hypoglycemia. The exercise and acute-illness limbs are not in our copy — METHODS p. 2 states subjects were maintained on absolute bed rest, and no passage reports epinephrine during heavy exercise or during acute illness; the DISCUSSION (p. 6) instead closes by saying a role for adrenergic mechanisms in 'more physiologic fluctuations' of plasma glucose 'remains to be established.' Searched: exercise/physical exertion, acute illness/stress, epinephrine >400 pg/ml. (LLM, conf=0.75)
- Not matchedcites [30]
The reference list we hold has no entry [30].
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose clearance declined and remained suppressed during the infusion of epinephrine at the higher infusion rates”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“glucose utilization did not change”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“but lower for increments in blood glycerol, 75–125 pg/ml”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
In the paper
“As noted previously (25), glucose production rose transiently, returning to near base line by 60 min”
What the sources say
- Not checked — no full text of the sourcecites [25] Rizza, R. A., M. W. Haymond, P. E. Cryer, and J. E. Gerich. 1979. Differential effects of physiologic concentrations of epinephrine on glucose production and disposal in man. Am. J. Physiol. 237: E356–E362. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
32 more claims
Create a free account to see all 47 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 7
- It may state two separate claims as one. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“plasma epinephrine concentrations do not commonly achieve the threshold level required to affect basal glucose metabolism (7).”
From Mechanisms of postprandial glucose counterregulation in man. Physiologic roles of glucagon and epinephrine vis-a-vis insulin in the prevention of hypoglycemia late after glucose ingestion (1983) · cites this paper as [7]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“a more than eightfold increase in mean plasma epinephrine to a level known to have hyperglycemic effects in man (38).”
From Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man (1984) · cites this paper as [38]
Citations
Cites
Effect of Ischemia on Known Substrates and Cofactors of the Glycolytic Pathway in Brain
Lowry, O. H., Passonneau, J. V., Hasselberger, F. X., & Schulz, D. W. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51740-3 · Cited by 2,221
Cryer, P. E., Haymond, M. W., Santiago, J. V., & Shah, S. D. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609092951101 · Cited by 1,101
Self-citationHormone-fuel interrelationships during fasting.
Cahill, G. F., Herrera, M. G., Morgan, A. P., Soeldner, J. S., Steinke, J., Levy, P. L., Reichard, G. A., & Kipnis, D. M. (1966) · Journal of Clinical Investigation · doi:10.1172/jci105481 · Cited by 1,036
A simplified radiometric assay for plasma norepinephrine and epinephrine
Passon, P. G., & Peuler, J. D. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90517-4 · Cited by 637
A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma
SCHALCH, D. S., & PARKER, M. L. (1964) · Nature · doi:10.1038/2031141a0 · Cited by 635
Measurement of “true” glucose production rates in infancy and childhood with 6,6-dideuteroglucose
Bier, D. M., Leake, R. D., Haymond, M. W., Arnold, K. J., Gruenke, L. D., Sperling, M. A., & Kipnis, D. M. (1977) · Diabetes · doi:10.2337/diab.26.11.1016 · Cited by 444
Self-citationGlucagon and plasma catecholamine responses to graded and prolonged exercise in man
Galbo, H., Holst, J. J., & Christensen, N. J. (1975) · Journal of Applied Physiology · doi:10.1152/jappl.1975.38.1.70 · Cited by 406
Immunoassay of Insulin Using a Two-Antibody System.
Morgan, C. R., & Lazarow, A. (1962) · Experimental Biology and Medicine · doi:10.3181/00379727-110-27411 · Cited by 367
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citationDetermination of norepinephrine apparent release rate and clearance in humans
Esler, M., Jackman, G., Bobik, A., Kelleher, D., Jennings, G., Leonard, P., Skews, H., & Korner, P. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90371-0 · Cited by 344
Cited by
Items 401–500 of 577
Epinephrine's ketogenic effect in humans is mediated principally by lipolysis
Avogaro, A., Cryer, P. E., & Bier, D. M. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.2.e250 · Cited by 14
Self-citationDrug receptors and control of the cardiovascular system: Recent advances
Ruffolo, R. R., Hieble, J. P., Brooks, D. P., Feuerstein, G. Z., & Nichols, A. J. (1991) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-7136-5_4 · Cited by 11
EFFECTS OF KETAMINE ANAESTHESIA ON THE METABOUC RESPONSE TO PELVIC SURGERY
Lacoumenta, S., WALSH, E. S., Waterman, A. E., Ward, I. D., PATERSON, J. L., & Hall, G. M. (1984) · British Journal of Anaesthesia · doi:10.1093/bja/56.5.493 · Cited by 12
“This glycaemic response is compatible with the well-documented activation of the sympathetic nervous system by ketamine (White, Way and Trevor, 1982), although it is curious that there were no changes in circulating lactate and NEFA concentrations which are, in part, mediated sympathetically (Clutter et al., 1980).”
BackgroundCryer, P. E. (1980) · Metabolism · doi:10.1016/0026-0495(80)90017-7 · Cited by 10
Self-citationDifferential blockade of alpha‐adrenoceptors by indoramin.
Nicholls, D., O'Connor, P., Harron, D. W. G., et al. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02409.x · Cited by 10
Adjustment of metabolism, catecholamines and ?-adrenoceptors to 90 min of cycle ergometry
Schuetz, W., Traeger, K., Anhäupl, T., Schanda, S., Rager, C., Vogt, J. A., & Georgieff, M. (1995) · European Journal of Applied Physiology · doi:10.1007/bf00601813 · Cited by 12
Regulation of Vascular Tone and Capillary Perfusion
Bertuglia, S., Colantuoni, A., & Intaglietta, M. (2000) · Springer eBooks · doi:10.1007/978-1-4612-1190-7_35 · Cited by 12
Khurana, M. L., Gupta, P., Khadgawat, R., Bal, C., Kumar, G., Sharma, S., & Tandon, N. (2015) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.163183 · Cited by 10
Sympathoadrenal activity during helox-cold induced hypothermia in syrian hamsters
Werner, R. (1992) · Comparative Biochemistry and Physiology Part A Physiology · doi:10.1016/0300-9629(92)90253-m · Cited by 9
Catecholamine physiology in ovine fetus. II. Metabolic clearance rate of epinephrine
Palmer, S. M., Oakes, G. K., LAM, R. W., Hobel, C. J., & Fisher, D. A. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.4.e350 · Cited by 9
The effects of epinephrine on islet hormone secretion in the dog
Ahrén, B., Veith, R. C., & Taborsky, G. J. (1988) · International Journal of Pancreatology · doi:10.1007/bf02788471 · Cited by 9
“In contrast, during administration of lower doses of epinephrine, plasma glucagon levels are often not altered [ 18-20 ], probably since the concomitant hyperglycemia impairs the glucagon secretory response to epinephrine [21].”
BackgroundKraus, C. N., Wargacki, S., Golden, D. M., et al. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.01.006 · Cited by 8
Physiopathologie de l’hyporéactivité vasculaire au cours des états de choc
Collin, S., & Lévy, B. (2008) · Réanimation · doi:10.1016/j.reaurg.2007.12.008 · Cited by 21
Hyperbaric stress in divers and non-divers: neuroendocrine and psychomotor responses.
McLellan, T. M., Wright, H. E., Rhind, S. G., et al. (2010) · PubMed · Cited by 8
Brown, M. J. (1995) · BMJ · doi:10.1136/bmj.311.7007.701 · Cited by 8
Eckerström, F., Rex, C. E., Maagaard, M., et al. (2018) · BMJ Open Sport & Exercise Medicine · doi:10.1136/bmjsem-2018-000397 · Cited by 8
Ohnishi, A., Minegishi, A., Sasaki, T., Suganuma, T., & Ishizaki, T. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03054.x · Cited by 8
The effects of adrenalectomy and autonomic blockades on the exercise tachycardia in conscious rats
Wakasugi, R., Nakamoto, T., & Matsukawa, K. (2010) · Autonomic Neuroscience · doi:10.1016/j.autneu.2010.01.007 · Cited by 7
“On the other hand, since the plasma epinephrine threshold of 50–100 pg/ml for increment in HR can be attained even during mild exercise (Clutter et al., 1980; Sonne and Galbo, 1980; Peronnet et al., 1981), plasma epinephrine plays a role in evoking the HR response during mild to moderate dynamic exercise.”
Hypertensive Crisis Caused by Hypoglycemia and Propranolol
Mann, S. J., & Krakoff, L. R. (1984) · Archives of Internal Medicine · doi:10.1001/archinte.1984.00350220159035 · Cited by 9
Yazawa, K., Adachi, W., Owa, M., et al. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520252903170 · Cited by 8
“The threshold of plasma epinephrine necessary to increase heart rate has been estimated to be 50– 100 pg/ml (25).”
BackgroundKurpad, A. V., Kulkarni, R. N., Vaz, M. A. P., et al. (1989) · Metabolism · doi:10.1016/0026-0495(89)90009-7 · Cited by 8
Kjeldsen, S. E., TAYLOR, I., Westheim, A. S., et al. (1987) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1987.tb02398.x · Cited by 8
Chaos evidence in catecholamine secretion at chromaffin cells
Quiroz, G., Bonifas, I., Barajas-Ramírez, J. G., & Femat, R. (2012) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2012.03.015 · Cited by 7
“There exist a wide number of biological effects induced by catecholamines [9].”
BackgroundCismaru, G. L., Roşu, R., Mureşan, L., Puiu, M., Andronache, M., Hengan, E., Ispas, D., Guşetu, G., Pop, D., Mircea, P. A., et al. (2014) · EP Europace · doi:10.1093/europace/euu042 · Cited by 9
Sprangers, F., Thien, H. V., Ackermans, M. T., Endert, E., & Sauerwein, H. P. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.01.008 · Cited by 8
Composite pheochromocytoma presenting as severe lactic acidosis and back pain: A case report
Rajagopalan, S., Kumar, R. M., Narayanan, N., & Raghunath, K. (2019) · Indian Journal of Nephrology · doi:10.4103/ijn.ijn_67_18 · Cited by 7
“have demonstrated that epinephrine increases heart rate, BP, blood glucose, lactate, and glycerol in normal subjects in a dose‐dependent manner.[8] This patient’s lactic acidosis can be classified as type B lactic acidosis since he had no signs and symptoms of hypoperfusion.”
BackgroundThe diabetic patient: a challenge or just routine?
Ralley, F. E. (1996) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03011665 · Cited by 5
The Role of Catecholamines in Metabolic Acidosis
Schade, D. S. (1982) · Novartis Foundation symposium · doi:10.1002/9780470720691.ch13 · Cited by 9
Metabolic and haemodynamic effects of dopamine plus domperidone in volunteers
ENSINGER, H., Lindner, K. H., Goertz, A. W., et al. (1993) · Research in Experimental Medicine · doi:10.1007/bf02576232 · Cited by 7
“In contrast to adrenaline [ 6 ], dopamine did not affect the plasma concentration of lactate.”
BackgroundSch�ttler, J., H�rnchen, U., Stoeckel, H., et al. (1987) · Langenbeck s Archives of Surgery · doi:10.1007/bf01254089 · Cited by 7
“Dagegen k6nnen durch Fl/ichenberechnungen unter der Konzentrationskurve Clearance-Werte gewonnen werden, die mit Werten von mehreren Litern pro Minute eine Gr6Benordnung aufweisen, die auch beim Menschen gefunden wurde [1].”
BackgroundTransient suppression of pancreatic endocrine function in patients following brain death
Yoshida, H., Hiraide, A., Yoshioka, T., & Sugimoto, T. (1996) · Clinical Transplantation · doi:10.1111/j.1399-0012.1996.tb00640.x · Cited by 5
Lactate Metabolism in Health and Disease
Kane, D. A., Goodwin, M. L., & Gladden, L. B. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-88361-3_24 · Cited by 10
A Narrative Review of Drug Therapy in Adult and Pediatric Cardiac Arrest
Jaeger, D., Marquez, A. M., Kosmopoulos, M., Gutiérrez, A., Gaisendrees, C., Orchard, D. A., Chouihed, T., & Yannopoulos, D. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2406163 · Cited by 6
“Its half-life in physiological settings is around 2 to 3 minutes [13].”
BackgroundNailfold capillary microscopy in lacunar infarction.
Ferri, C., Pitaro, N., Giuggioli, D., Martini, A., Carabelli, E., Giraldi, C., & MURATORIO, A. (1994) · Stroke · doi:10.1161/01.str.25.2.525 · Cited by 6
Generalized Tonic-Clonic Epilepsies
Fisch, B. J., & Pedley, T. A. (1987) · Clinical medicine and the nervous system · doi:10.1007/978-1-4471-1401-7_8 · Cited by 6
The autonomic and neurohumoral response to critical illness
Goldstein, B., & Woolf, P. D. (1996) · Clinical Intensive Care · doi:10.3109/tcic.7.6.297.307 · Cited by 6
Hyperkaliémie sévère ou menaçante : le diable est dans les détails
Robert, T., Algalarrondo, V., & Mesnard, L. (2015) · Réanimation · doi:10.1007/s13546-015-1125-8 · Cited by 8
Large-Dose Epinephrine Reduces Skeletal Muscle Blood Flow Under General Anesthesia in Rabbits
Terakawa, Y., & Ichinohe, T. (2012) · Anesthesia Progress · doi:10.2344/12-00006.1 · Cited by 6
Modulation of Arginine-Induced Glucagon Release by Epinephrine and Glucose Levels in Man*
Beard, J. C., Weinberg, C. R., Pfeifer, M. A., Best, J. D., Halter, J. B., & Porte, D. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-56-6-1271 · Cited by 6
Wada, A., Arita, M., Takara, H., et al. (1989) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00717734 · Cited by 6
Takei, M., Furukawa, Y., Narita, M., et al. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90574-n · Cited by 6
Editorial: Arterial Plasma Adrenaline in Essential Hypertension
Kjeldsen, S. E., & Eide, I. A. (1984) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365518409083807 · Cited by 6
Lack of effect of somatostatin on epinephrine-stimulated glucose production in the dog
Stevenson, R. W., Steiner, K., Williams, P. E., & Cherrington, A. D. (1987) · Metabolism · doi:10.1016/0026-0495(87)90042-4 · Cited by 6
JOHNSON, M. D. (1983) · Endocrinology · doi:10.1210/endo-112-1-18 · Cited by 6
Splanchnic and renal contribution to disposal of infused epinephrine in humans
Saccà, L., Hendler, R., Picardi, A., & Sherwin, R. S. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.251.3.e285 · Cited by 6
Maggs, D. G., GALLEN, I. W., Fone, K. C. F., & Macdonald, I. A. (1994) · Clinical Autonomic Research · doi:10.1007/bf01845777 · Cited by 5
Ninomiya, A., Terakawa, Y., Matsuura, N., et al. (2012) · Anesthesia Progress · doi:10.2344/10-17.1 · Cited by 5
“At plasma epinephrine concentrations below 400 pg/mL, b-adrenegic effects are dominant; at 400 pg/mL and above, both a- and badrenergic effects are observed.(14,15) The peak plasma epinephrine concentration after oral mucosal injection of LE in our study is predicted as approximately 1000 pg/mL.”
BackgroundPharmacological Heart Failure Therapy in Children: Focus on Inotropic Support
Schranz, D. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_267 · Cited by 5
Fisiopatología, importancia y utilidad del lactato en pacientes con sepsis*
Muñoz, M. L. Z., & Barragan, F. J. (2010) · IATREIA · doi:10.17533/udea.iatreia.8457 · Cited by 5
Hauk, P. J., Otto, J., Schwab, K., Kaufmehl, K., Urbanek, R., Eichler, H. G., & Förster, J. (1995) · Pediatric Research · doi:10.1203/00006450-199512000-00028 · Cited by 5
Low-dose epinephrine supports plasma glucose in fasted elderly patients with type 2 diabetes
Burge, M. R., Kamin, J., Timm, C., Qualls, C., & Schade, D. S. (2000) · Metabolism · doi:10.1016/s0026-0495(00)91273-3 · Cited by 5
Meptazinol and Pentazocine: Effects on Prolactin, Growth Hormone and Vasopressin Levels in Plasma
Manner, T., Kanto, J., Scheinin, H., Viinamäki, O. V. K., & Scheinin, M. (1987) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1987.tb01823.x · Cited by 5
Different Norepinephrine Disappearance Rate in Venous and Arterial Plasma in Man
Saar, N., Bachmann, A. W., Jackson, R. V., et al. (1983) · Clinical and Experimental Hypertension · doi:10.3109/10641968309048808 · Cited by 5
Song, G., You, Y., Jeong, W., et al. (2016) · Clinical and Experimental Emergency Medicine · doi:10.15441/ceem.15.090 · Cited by 5
Physiology of the autonomic nervous system
Green, J. H. (1990) · Springer eBooks · doi:10.1007/978-1-4899-2919-8_2 · Cited by 5
Stress, Behavior, and the Autonomic Nervous System in Type II Diabetes Mellitus
Surwit, R. S., Ross, S. L., & Feinglos, M. N. (1990) · Contributions to psychology and medicine · doi:10.1007/978-1-4612-3290-2_10 · Cited by 5
Ohashi, H., Miura, Y., Kimura, S., Ishizuka, Y., Sugawara, T., TORIYABE, S., Noshiro, T., Takahashi, M., Sano, N., Watanabe, H., et al. (1985) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.49.1019 · Cited by 5
Gordon, R. D., Bachmann, A. W., Ballantine, D. M., & Thompson, R. E. (1991) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1991.tb01448.x · Cited by 5
Fasting glucose production in the smaller of twins with epinephrine-deficient hypoglycemia
Kerr, D. S., & Picou, D. I. M. (1981) · Metabolism · doi:10.1016/0026-0495(81)90213-4 · Cited by 4
CIRCULATING CATECHOLAMINES IN ASTHMA
Barnes, P. J. (1981) · Clinical Physiology · doi:10.1111/j.1475-097x.1981.tb00945.x · Cited by 5
Effects of lidocaine with epinephrine on fear related arousal among dental phobics.
Fiset, L. O., Ramsay, D. S., Milgrom, P., et al. (1986) · PubMed · Cited by 5
Catecholamine Sulfates and Platelet Phenolsulfotransferase (PST) Activity in Human Hypertension
Küchel, O., Buu, N. T., Hamet, P., et al. (1981) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-06118-1_13 · Cited by 5
Adrenomedullary Catecholamines
Epple, A. W. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-629055-4.50017-9 · Cited by 5
Epinephrine kinetics in septic shock – a means to understand variable catecholamine efficiency?
Calzia, E., Georgieff, M., Huber-Lang, M. S., & Radermacher, P. (2009) · Critical Care · doi:10.1186/cc7987 · Cited by 4
Feeding practice in acute stroke patients in a tertiary care hospital
Miah, M. T., Al-Amin, M., Khan, M. A. I., Ayaz, K., Zakaria, M., Ahmed, S., & Ahasan, H. N. (1970) · Bangladesh Medical Research Council Bulletin · doi:10.3329/bmrcb.v36i3.7286 · Cited by 4
Comparison of two vasoconstrictors on glycemic levels in diabetic patients
Santos, D. M., Amorim, K. D. S., Dantas, A. C. G. C., da Silva, R. P., de Araújo, J. S. M., Groppo, F. C., & Souza, L. M. A. (2020) · Clinical Oral Investigations · doi:10.1007/s00784-020-03327-z · Cited by 7
PERNET, A., JOHNSTON, D. G., HAMMOND, V., ØRSKOV, H., & ALBERTI, K. G. M. M. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01347.x · Cited by 4
Saleh, N., Elayan, H. E., & Zihlif, M. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.184 · Cited by 5
“E release is diminished in the elderly (20) especially during exercise (21).”
BackgroundSTRESS, HYPERTENSION, AND THE HEART: THE ADRENALINE TRILOGY
(1982) · The Lancet · doi:10.1016/s0140-6736(82)91336-8 · Cited by 4
Geisser, W., Vogt, J. A., Wachter, U. A., Hofbauer, H., Georgieff, M., & ENSINGER, H. (2004) · Intensive Care Medicine · doi:10.1007/s00134-003-2124-1 · Cited by 4
“exogenously infused, do not only mediate haemodynamic actions but have also profound metabolic effects including hyperglycaemia, an increase in lipolysis and oxygen consumption [6, 7, 8, 9].”
BackgroundWalsh, K. M., Adams, C., Sinclair, A., et al. (1998) · Clinical Science · doi:10.1042/cs0940121 · Cited by 4
Tissue Lactate Concentrations in Critical Illness
Venkatesh, B., & Morgan, T. J. (2002) · Intensive Care Medicine · doi:10.1007/978-1-4757-5551-0_53 · Cited by 4
The Sympathochromaffin System and the Pituitary-Adrenocortical Response to Hypoglycemia
Cryer, P. E. (1986) · Science · doi:10.1126/science.3001939 · Cited by 4
Self-citationBarnett, A. H., Maslowski, A. H., Livesey, J., Nicholls, G. M., Ikram, H., & Espiner, E. A. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01299.x · Cited by 4
Abrahamsen, J. (1991) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1991.tb01613.x · Cited by 4
Recent Experimental and Conceptual Advances in Drug Receptor Research in the Cardiovascular System
Ruffolo, R. R., Jr., & Nichols, A. J. (1988) · Advances in Drug Research · doi:10.1016/b978-0-12-013317-8.50007-1 · Cited by 4
Ionic perturbation of agonist binding to brain muscarinic receptors [proceedings].
Berrie, C. P., Birdsall, N. J. M., Burgen, A. S. V., et al. (1979) · PubMed · Cited by 4
Sch�ttler, J., H�rnchen, U., Stoeckel, H., et al. (1987) · Cited by 4
Rokamp, K. Z., Dela, F., Secher, N. H., Grønlykke, L., Thorsteinsson, B., & Pedersen‐Bjergaard, U. (2023) · Diabetes · doi:10.2337/db22-0718 · Cited by 3
The Significant Role of Physical Activity and Exercise in Health and Metabolic Diseases
Dimitriadis, G., Chryssanthopοulos, C., Philippou, Α., & Koutsilieris, M. (2025) · Physiologia · doi:10.3390/physiologia5040057 · Cited by 12
“This study [78] and others [13,79–85] described the hormonal changes and energy sources involved during aerobic exercise.”
Social Determinants of Diabetes
Singh, M., & Khan, A. (2015) · Journal of Clinical & Medical Genomics · doi:10.4172/2472-128x.1000126 · Cited by 3
“‖ Therefore is somewhere shows that the present diabetes management strategy in diabetic patients and diabetes prevention strategy in non-diabetic individual has failed to a large extent, therefore it gives us a signal to explore the social dimension of this disease more specifically at the individual levels [71-80].”
BackgroundEngland, L. J., Syms, C. A., & York, C. (2021) · Otology & Neurotology · doi:10.1097/mao.0000000000003128 · Cited by 3
Cardiovascular Pharmacology in Pediatric Patients with Congenital Heart Disease
Dabbagh, A., Talebi, Z., & Rajaei, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-10442-8_4 · Cited by 4
Pain Management and Comfortable Treatment in Micro Prosthodontics
Yu, H. (2022) · Springer eBooks · doi:10.1007/978-981-19-0256-7_5 · Cited by 3
Sympathetic nervous system and metabolism
Carlson, G., & Little, R. (1999) · Springer eBooks · doi:10.1007/978-88-470-2901-9_6 · Cited by 3
Chalew, S. A., Sakamoto, R. N., McCarter, R., et al. (1989) · Journal of Clinical Monitoring and Computing · doi:10.1007/bf01618252 · Cited by 3
“The increasing levels of epinephrine over 100 pg/ml before the glucose nadir are capable of causing the associated rise in heart rate [26].”
BackgroundUse of N2O/O2/enflurane anesthesia for dental treatment of the handicapped
Ogawa, A., & Oi, K. (1991) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(91)90367-u · Cited by 3
Du, S., Joyner, M. J., Curry, T. B., Eisenach, J. H., Johnson, C. P., Schrage, W. G., & Jensen, M. D. (2014) · Physiological Reports · doi:10.14814/phy2.12017 · Cited by 3
“However, in vitro differences in lipolysis may not translate readily to the in vivo situation because of the complicated regulation of neuroendocrine and adipose tissue blood flow (Clutter et al. 1980; Hjemdahl and Linde 1983).”
BackgroundDemonstration of a different sensitivity to epinephrine in isolated and in vivo hearts
Latini, R., Zuanetti, G., Conforti, L., et al. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90150-1 · Cited by 3
Olubadewo, J. O., & Heimberg, M. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90225-l · Cited by 3
Pheochromocytoma Presenting as Systemic Inflammatory Response Syndrome and Lactic Acidosis
Radhi, S., NUGENT, K. M., & Alalawi, R. H. (2010) · ICU Director · doi:10.1177/1944451610383981 · Cited by 3
Pharmacology of the Cardiovascular System
Kelly, M., Sturgill, M. G., & Notterman, D. A. (2006) · Elsevier eBooks · doi:10.1016/b978-032301808-1.50026-2 · Cited by 3
Epinephrine does not impair utilization of exogenous amino acids in humans
Schiefermeier, M., Ratheiser, K., Zauner, C., Roth, E., Eichler, H.-G., & Matthews, D. E. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.6.1765 · Cited by 3
Hypoglycemia-Associated Autonomic Failure in Diabetes
Cryer, P. E., & Arbeláez, A. M. (2018) · Contemporary Endocrinology · doi:10.1007/978-3-319-77048-2_13 · Cited by 5
Self-citationModified Hormonal Effects on Fat Metabolism after Severe Head Injury in Children
Matthews, D. S. F., Aynsley-Green, A., & Eyre, J. A. (1996) · Pediatric Research · doi:10.1203/00006450-199606000-00014 · Cited by 3
Bachmann, A. W., Gordon, R. D., Bathgate, R. A. D., et al. (1990) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1990.tb01317.x · Cited by 3
“Studies in normal subjects suggest that increments of ADR in the physiological range can enhance its clearance rate (Clutter et al. 1980; Sanfield et al. 1985).”
BackgroundGordon, R. D., Bachmann, A. W., Gueizelar, B. T., & Dai, Y. (1987) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1987.tb00369.x · Cited by 3
Role of Catecholamines in the Ketonemic Response to Somatostatin in Normal Man*
Beaufrère, B., Beylot, M., Riou, J. P., Sérusclat, P., Cohen, R., Souquet, J.-C., & Mornex, R. (1983) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-57-4-847 · Cited by 3
“However, in these two studies, the Epi levels were largely above the threshold values (150-200 ng/liter) that have been shown to increase BG level and hepatic glucose production (22).”
BackgroundYOSHITAKE, Y. (1986) · Nippon Eiseigaku Zasshi (Japanese Journal of Hygiene) · doi:10.1265/jjh.40.867 · Cited by 3
Developmental Pharmacology of Adrenergic Agents
Padbury, J. F., & Berg, R. A. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-3479-7.10025-4 · Cited by 3
Metadata
- Authors
- Clutter, W. E., Bier, D. M., Shah, S. D., & Cryer, P. E.
- Affiliations
- Washington University in St. Louis (US)
- ORCID
- Bier, D M
- Venue
- Journal of Clinical Investigation
- Published
- 1980-07-01
- Volume
- 66
- Issue
- 1
- Pages
- 94-101
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC371510
- OpenAlex
- W2133884882
- Cited by
- 576
- References
- 31
- Citations by year
- 2026: 2 · 2025: 5 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 9 · 2017: 3 · 2016: 3 · 2015: 9 · 2014: 5 · 2013: 5 · 2012: 5
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- epinephrine, norepinephrine, heart rate, blood pressure, blood glucose, blood lactate, beta-hydroxybutyrate, insulin, hemodynamic effects, metabolic effects, dose-response relationship
- MeSH terms
- Adult, Blood Glucose, Blood Pressure, Dose-Response Relationship, Drug, Epinephrine, Female, Glucagon, Heart Rate, Humans, Insulin, Kinetics, Male, Metabolic Clearance Rate, Norepinephrine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.